Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Return on Assets (2021 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Return on Assets for 5 consecutive years, with 0.51% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Assets fell 18.0% year-over-year to 0.51%, compared with a TTM value of 0.51% through Jun 2025, down 18.0%, and an annual FY2023 reading of 0.3%, down 32.0% over the prior year.
  • Return on Assets was 0.51% for Q2 2025 at Barinthus Biotherapeutics, down from 0.31% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.03% in Q3 2022 and bottomed at 0.51% in Q2 2025.
  • Average Return on Assets over 5 years is 0.16%, with a median of 0.08% recorded in 2021.
  • The sharpest move saw Return on Assets grew 10bps in 2022, then plummeted -36bps in 2023.
  • Year by year, Return on Assets stood at 0.08% in 2021, then surged by 122bps to 0.02% in 2022, then crashed by -1908bps to 0.33% in 2023, then grew by 7bps to 0.31% in 2024, then tumbled by -66bps to 0.51% in 2025.
  • Business Quant data shows Return on Assets for BRNS at 0.51% in Q2 2025, 0.31% in Q3 2024, and 0.33% in Q2 2024.